The critical pathogenic role of tumor necrosis factor (TNF)α in … in both the treatment and
pathogenesis of cancer remains less … therapy for clinical treatment of cancers in distinct settings. …

Exceptional advances have been made recently in our understanding of the signaling pathways
that control cellular growth, differentiation, and survival. These processes are regulated …

… an important role in the treatment of cancer as it is a popular target of many treatment
strategies. The abundance of literature suggests that targeting apoptosis in cancer is feasible. …

… in the etio-pathogenesis, diagnosis and management of breast cancer. We have attempted
… and hope that it will serve as a reference for clinicians who treat patients with breast cancer. …

… a possible role for this receptor in the pathogenesis of cancer. In this regard, evidence is …
observations imply a role for the constitutive activation of CD40L in cancer pathogenesis. …

… involved in the pathogenesis and treatment of various types of cancer, including breast cancer.
In … that called oncomiRs and their role in the pathogenesis and treatment of breast cancer. …

… factors involved in cancer pathogenesis are identified, potential … for cancer patients. Numerous
antiangiogenic therapies are now approved for the treatment of a broad range of cancers, …

… its low response to treatment and its highly invasive nature. Future therapeutic concepts for
… cancer aim to individualize therapy and de-escalate and escalate treatment based on cancer …

Biologically active sphingolipids have key roles in the regulation of several fundamental
biological processes that are integral to cancer pathogenesis. Recent significant progress in …

Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer patients
at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant influence …